vorasidenib
servier
['hncsm', 'vorasidenib', 'indigo']
indigo results just presented at #asco23: vorasidenib significantly reduced the risk of disease progression or death compared with placebo in patients with idh-mutant grade 2 glioma: #ascodailynews #hncsm 
Account of the American Society of Clinical Oncology & its affiliate the Association for Clinical Oncology. Assoc tweets labeled #ASCOAdvocacy. RTs ≠ endorse.